Literature DB >> 21167814

Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.

S M Chajkowski1, J Mallela, D E Watson, J Wang, C R McCurdy, J M Rimoldi, Z Shariat-Madar.   

Abstract

We have previously cloned a cDNA encoding human prolylcarboxypeptidase (PRCP) and expressed the cDNA in the Schneider 2 (S2) drosophila cell line. Here, we further characterized this recombinant enzyme. Investigations were performed to determine whether recombinant PRCP (rPRCP) metabolizes kinins (BK 1-9 and BK 1-8). The metabolites of these kinins were identified by LC/MS. rPRCP metabolized BK 1-8 to BK 1-7, whereas rPRCP was ineffective in metabolizing BK 1-9. The hydrolysis of BK 1-8 by rPRCP was dose- and time-dependent. A homology model of PRCP was developed based upon the sequence of dipeptidyl-peptidase 7 (DPP7, PDB ID: 3JYH), and providentially, the structure of PRCP (PDB ID: 3N2Z) was characterized during the course of our investigation. Docking studies of bradykinin oligopeptides were performed both from the homology model, and from the crystal structure of PRCP. These docking studies may provide a better understanding of the contribution of specific residues involved in substrate selectivity of human PRCP.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167814      PMCID: PMC3052280          DOI: 10.1016/j.bbrc.2010.12.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.

Authors:  E Hooley; P A McEwan; J Emsley
Journal:  J Thromb Haemost       Date:  2007-10-08       Impact factor: 5.824

2.  Carboxypeptidase M in Madin-Darby canine kidney cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor.

Authors:  P A Deddish; R A Skidgel; V B Kriho; X Y Li; R P Becker; E G Erdös
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

Review 3.  The kallikrein-kinin system in humans.

Authors:  D J Campbell
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-12       Impact factor: 2.557

4.  Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

5.  Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits.

Authors:  Lisa M Duke; Gabriela A Eppel; Robert E Widdop; Roger G Evans
Journal:  Hypertension       Date:  2003-07-07       Impact factor: 10.190

6.  Recombinant prolylcarboxypeptidase activates plasma prekallikrein.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

Review 7.  The renin-angiotensin system and malignancy.

Authors:  Eleanor I Ager; Jaclyn Neo; Christopher Christophi
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

8.  The functional importance of the N-terminal region of human prolylcarboxypeptidase.

Authors:  J Mallela; R Perkins; J Yang; S Pedigo; J M Rimoldi; Z Shariat-Madar
Journal:  Biochem Biophys Res Commun       Date:  2008-07-24       Impact factor: 3.575

Review 9.  Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists.

Authors:  J N Sharma; G J Al-Sherif
Journal:  ScientificWorldJournal       Date:  2006-10-09

10.  Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation.

Authors:  My-Linh Ngo; Fakhri Mahdi; Dhaval Kolte; Zia Shariat-Madar
Journal:  J Inflamm (Lond)       Date:  2009-01-27       Impact factor: 4.981

View more
  12 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Global identification of peptidase specificity by multiplex substrate profiling.

Authors:  Anthony J O'Donoghue; A Alegra Eroy-Reveles; Giselle M Knudsen; Jessica Ingram; Min Zhou; Jacob B Statnekov; Alexander L Greninger; Daniel R Hostetter; Gang Qu; David A Maltby; Marc O Anderson; Joseph L Derisi; James H McKerrow; Alma L Burlingame; Charles S Craik
Journal:  Nat Methods       Date:  2012-09-30       Impact factor: 28.547

3.  Proteome-derived peptide libraries to study the substrate specificity profiles of carboxypeptidases.

Authors:  Sebastian Tanco; Julia Lorenzo; Javier Garcia-Pardo; Sven Degroeve; Lennart Martens; Francesc Xavier Aviles; Kris Gevaert; Petra Van Damme
Journal:  Mol Cell Proteomics       Date:  2013-04-25       Impact factor: 5.911

4.  Prolylcarboxypeptidase promotes angiogenesis and vascular repair.

Authors:  Gregory N Adams; Evi X Stavrou; Chao Fang; Alona Merkulova; M Amer Alaiti; Kohsuke Nakajima; Toshifumi Morooka; Sergei Merkulov; Gretchen A Larusch; Daniel I Simon; Mukesh K Jain; Alvin H Schmaier
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113

5.  Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke.

Authors:  Kaat Kehoe; Raf Brouns; Robert Verkerk; Sebastiaan Engelborghs; Peter Paul De Deyn; Dirk Hendriks; Ingrid De Meester
Journal:  Neurochem Res       Date:  2014-11-05       Impact factor: 3.996

6.  Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.

Authors:  Christoph Maier; Ines Schadock; Philipp K Haber; Jan Wysocki; Minghao Ye; Yashpal Kanwar; Christopher A Flask; Xin Yu; Brian D Hoit; Gregory N Adams; Alvin H Schmaier; Michael Bader; Daniel Batlle
Journal:  J Mol Med (Berl)       Date:  2017-02-03       Impact factor: 4.599

7.  High molecular weight kininogen activates B2 receptor signaling pathway in human vascular endothelial cells.

Authors:  Dhaval Kolte; Noah Osman; Jia Yang; Zia Shariat-Madar
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

8.  Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).

Authors:  J Wang; A Matafonov; H Madkhali; F Mahdi; D Watson; A H Schmaier; D Gailani; Z Shariat-Madar
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

9.  Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Authors:  Kevin M Wheelock; Jian Cai; Helen C Looker; Michael L Merchant; Robert G Nelson; Gudeta D Fufaa; E Jennifer Weil; Harold I Feldman; Ramachandran S Vasan; Paul L Kimmel; Brad H Rovin; Michael Mauer; Jon B Klein
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Prolyl carboxypeptidase activity in the circulation and its correlation with body weight and adipose tissue in lean and obese subjects.

Authors:  Kaat Kehoe; Heidi Noels; Wendy Theelen; Emilie De Hert; Shenguan Xu; An Verrijken; Thierry Arnould; Erik Fransen; Nina Hermans; Anne-Marie Lambeir; Per Venge; Luc Van Gaal; Ingrid De Meester
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.